Wodtke, R., Laube, M., Hauser, S., Meister, S., Ludwig, F., Fischer, S., . . . Löser, R. (2024). Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2. EJNMMI Radiopharmacy & Chemistry, 8(1), 1. https://doi.org/10.1186/s41181-023-00231-1
Chicago Style (17th ed.) CitationWodtke, Robert, Markus Laube, Sandra Hauser, Sebastian Meister, Friedrich-Alexander Ludwig, Steffen Fischer, Klaus Kopka, Jens Pietzsch, and Reik Löser. "Preclinical Evaluation of an 18F-labeled Nε-acryloyllysine Piperazide for Covalent Targeting of Transglutaminase 2." EJNMMI Radiopharmacy & Chemistry 8, no. 1 (2024): 1. https://doi.org/10.1186/s41181-023-00231-1.
MLA (9th ed.) CitationWodtke, Robert, et al. "Preclinical Evaluation of an 18F-labeled Nε-acryloyllysine Piperazide for Covalent Targeting of Transglutaminase 2." EJNMMI Radiopharmacy & Chemistry, vol. 8, no. 1, 2024, p. 1, https://doi.org/10.1186/s41181-023-00231-1.